RxDoctor Payments Data

Roger Gregush, DO

Orthopaedic Surgery · Wausau, WINPI 1164942413

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Stryker at 49.9% of the total. Reporting peaked in 2024 at $3,663 and has fallen 79.7% since, to $743 in 2025.

$8,423in general payments, 2019–2025

Across 53 payments — averaging $158.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Smith+Nephew$2K
  • Mid-atlantic Surgical Systems, LLC$1K
  • Medical Device Business Services, Inc.$443
  • Johnson & Johnson$401
  • Orthalign Inc$84
  • plus $97 from 5 others

What the payments were for

  • Travel & lodging$4,16149%
  • Food & beverage$3,06236%
  • Education$1,20014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,423 in reported general payments places this provider in the 70th percentile of 498 orthopaedic surgery providers in Wisconsin.

See all orthopaedic surgery providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$138,726
Medicare patients
170
Services billed
2,370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$12,843
Doxycycline Monohydrate45$6,761
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen185$1,881
Ondansetron OdtOndansetron153$1,640
Cefadroxil117$1,458
Mupirocin184$1,369
Rifampin27$856
Naproxen102$380
Levofloxacin30$313
Clindamycin Hcl26$280
Meloxicam83$156
Methylprednisolone20$131
Ondansetron Hcl13$86
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$80
Tramadol Hcl20$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Wausau

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →